NASDAQ NMS - GLOBAL MARKET · KALA
-2.38% · -$0.0200 · Vol 100.8K
Market closed · last close 4:00 PM ET · price as of 15:59:09 ET
KALA BIO Inc

KALA BIO Inc

Biotechnology
$0.8201
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
KALA
KALA BIO Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
AVOID

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

23/ 100
Veridion Score
AVOID · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is KALA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading KALA catalysts
About KALA BIO Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2017
Employees
6
Country
US

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.9840
Day high
$0.9840
Day low
$0.8000
Previous close
$0.8401
52W high
$981.50
-99.92% from high
52W low
$0.6103
0% of range
Market cap
$15.9M
EPS
$-24.2400
Beta
2.08
Shares out
19.3M
Volume
100.8K
0.92× rel vol
Avg volume
109.6K
VWAP
$0.8590
Price history computed in-house
1W
-9.90%
1M
+29.31%
3M
-62.21%
1Y
-99.82%
YTD
-97.05%
SMA 50 $1.41 · below
SMA 200 $15.38 · below
52W position 0%

KALA overview

Veridion Score
23
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around KALA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading KALA Form 4 filings
Public disclosures

Congress activity in KALA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for KALA in the cached public ledger.

Federal contracts

KALA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KALA in this window.
Lobbying spend

KALA lobbying filings, year to date.

Registered lobbying filings matched to KALA BIO Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KALA in this window.
Loading news for KALA
Analyst ratings
Sovereign unlock shows live analyst consensus for KALA.
Options
Sovereign unlock shows live options positioning for KALA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.